Compare McKesson Corporation (MCK) vs Pan American Silver Corp. Common Stock (PAAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Pan American Silver Corp. Common Stock — how do they compare? McKesson Corporation trades at $938.84 (market cap $108.46B), while Pan American Silver Corp. Common Stock trades at $46.27 (market cap $18.72B). The key difference: McKesson Corporation is far larger — about 5.8× Pan American Silver Corp. Common Stock's market cap, and Pan American Silver Corp. Common Stock pays the higher dividend (1.62%). Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Pan American Silver Corp. Common Stock for 1 Days on average.
| MCK | PAAS | |
|---|---|---|
Market Cap | $108.46B | $18.72B |
Volume | 712,607 | 2,957,838 |
Sector | Health | Basic Materials |
52-Week High | $995.69 | $68.70 |
52-Week Low | $725.17 | $33.20 |
Typical Hold Time | 74 Days | 1 Days |
Enterprise Value | $115.00B | $17.86B |
Dividend Yield | 0.4% | 1.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $930.25, up 2.19% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent news highlights the extension of McKesson's pharmaceutical distribution agreement with CVS Health through 2032, reinforcing long-term revenue visibility. Revenue growth remains robust, climbing from $264.0B in 2022 to $359.1B in 2025, though net margins are thin at 1.12%.
McKesson presents a favorable risk-reward profile with 81% analyst buy ratings and a $956.43 consensus price target offering 2.8% upside. Key risks include margin pressure from drug pricing dynamics and policy uncertainty. The company's strong cash flow generation ($6.1B operating cash flow in 2025) and strategic focus on oncology and specialty distribution support continued growth, though investors should monitor debt levels and competitive pressures in healthcare distribution.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Pan American Silver Corp. Common Stock
Pan American Silver is a mining company focused on silver and gold production in the Americas. It also explores and develops precious metals properties.
Read more on PAAS →
